W81K0425FA010↗
Center for Disease Detection, LLC received this contract from W40M USA Hca, Department of the Army: $4.91M obligated so far for reference laboratory testing. Its period of performance ended 2026-02-27.
Key facts · data as of Oct 26, 2026
- Recipient
- Center for Disease Detection, LLC
- Awarding agency
- Department of the Army (Department of Defense)
- Contracting office
- W40M USA Hca (W81K04)
- Obligated to date
- $4.91M
- Potential value
- $4.91M
- Ends
- 2026-02-27
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award W81K0425FA010, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_W81K0425FA010_9700_W81K0425DA002_9700
Center for Disease Detection, LLC: all federal awards · Department of Defense: spending · W40M USA Hca: what it buys
PROVIDE MEDICAL LABORATORY TESTING SERVICES FOR THE DETECTION OF ANTIGEN AND ANTIBODIES OF HUMAN IMMUNODEFICIENCY VIRUS(ES) (HIV), HEPATITIS B SURFACE ANTIBODY (HBSAB), HEPATITIS B SURFACE ANTIGEN (HBSAG), AND HEPATITIS C VIRUS (ANTI-HCV)
What it is
- Product or service
- Reference Laboratory Testing (PSC Q301)
- Industry
- Medical Laboratories (NAICS 621511)
- Contracting office
- W40M USA Hca (W81K04)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under W81K0425DA002
- Where the work is
- Bexar, TX · district TX-21
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
1 action since 2025-02-27. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-02-27 | 0 | $4.91M | PROVIDE MEDICAL LABORATORY TESTING SERVICES FOR THE DETECTION OF ANTIGEN AND ANTIBODIES OF HUMAN IMMUNODEFICIENCY VIRUS(ES) (HIV), HEPATITIS B SURFACE ANTIBODY (HBSAB), HEPATITIS B SURFACE ANTIGEN (HBSAG), AND HEPATITIS C VIRUS (ANTI-HCV) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗